Derivation of suitable biomonitoring methods to determine the current work-related lead exposure of employees

Derivation of suitable biomonitoring methods to determine the current work-related lead exposure of employees - BAuA F 2510

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025448

Enrollment

Registered

2021-06-18

Start date

2021-10-28

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lead and lead-associated health risks

Interventions

Group 1: External (inhalative and dermal) and internal lead exposure will be determined. The internal exposure will be assessed by biomonitoring (lead in blood, urine and plasma, effect markers). Curr

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years (legal age), male

Exclusion criteria

Exclusion criteria: kidney disease, neurological disease, anaemia for reasons other than lead

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the determination of the current inhalative and dermal lead exposure as well as the internal lead exposure and its variation depending on the activities performed and the protective measures via simultaneous measurements at the workplace, biomonitoring and questionnaire. The measurements are made during one workweek, with a repetition after one year.	—

Secondary

Measure	Time frame
effect parameters in blood and urine (delta-aminolaevulinic acid, ...)	—

Countries

Germany

Contacts

Public ContactAnna Wolfschmidt-Fietkau

Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin der Friedrich-Alexander-Universität Erlangen-Nürnberg

anna.wolfschmidt@fau.de091318526114

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026